Diagnosis and Treatment of Plasmodium Vivax Malaria

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2016 Oct 7

PMID 27708191

Citations 47

Authors

J Kevin Baird

Neena Valecha

Stephan Duparc

Nicholas J White

Ric N Price

Affiliations

Soon will be listed here.

Abstract

The diagnosis and treatment of Plasmodium vivax malaria differs from that of Plasmodium falciparum malaria in fundamentally important ways. This article reviews the guiding principles, practices, and evidence underpinning the diagnosis and treatment of P. vivax malaria.

Citing Articles

Influence of Household Roof Types on the Development of Plasmodium vivax in Anopheles stephensi Mosquitoes.

Ravishankaran S, Asokan A, Justin N, Surya R J, Mathai M, Eapen A Am J Trop Med Hyg. 2024; 112(2):286-295.

PMID: 39626288 PMC: 11803658. DOI: 10.4269/ajtmh.24-0243.

Recurrence patterns and evolution of submicroscopic and asymptomatic Plasmodium vivax infections in malaria-endemic areas of the Peruvian Amazon.

Garcia Castillo S, Abanto Alvarez C, Rosas-Aguirre A, Acosta C, Corder R, Gomez J PLoS Negl Trop Dis. 2024; 18(10):e0012566.

PMID: 39480785 PMC: 11527163. DOI: 10.1371/journal.pntd.0012566.

Transmission-blocking activities of artesunate, chloroquine, and methylene blue on gametocytes.

Chaumeau V, Wasisakun P, Watson J, Oo T, Aryalamloed S, Sue M Antimicrob Agents Chemother. 2024; 68(9):e0085324.

PMID: 39058023 PMC: 11382624. DOI: 10.1128/aac.00853-24.

Expression, Purification, and Characterization of Lactate Dehydrogenase from Bacteria without Codon Optimization.

Kim Y, Shin J, Lee K, Eom H, Jo B, Lee J Int J Mol Sci. 2023; 24(13).

PMID: 37446261 PMC: 10342390. DOI: 10.3390/ijms241311083.

Village malaria workers for the community-based management of vivax malaria.

Adhikari B, Tripura R, Peto T, Callery J, von Seidlein L, Dysoley L Lancet Reg Health Southeast Asia. 2023; 9:100128.

PMID: 37383038 PMC: 10306055. DOI: 10.1016/j.lansea.2022.100128.

References

Golenda C, Li J, Rosenberg R . Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc Natl Acad Sci U S A. 1997; 94(13):6786-91. PMC: 21236. DOI: 10.1073/pnas.94.13.6786. View

Cappellini M, Fiorelli G . Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008; 371(9606):64-74. DOI: 10.1016/S0140-6736(08)60073-2. View

Tjitra E, Anstey N, Sugiarto P, Warikar N, Kenangalem E, Karyana M . Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008; 5(6):e128. PMC: 2429950. DOI: 10.1371/journal.pmed.0050128. View

Baird K, Maguire J, Price R . Diagnosis and treatment of Plasmodium vivax malaria. Adv Parasitol. 2012; 80:203-70. DOI: 10.1016/B978-0-12-397900-1.00004-9. View

Wells T, Burrows J, Baird J . Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010; 26(3):145-51. DOI: 10.1016/j.pt.2009.12.005. View

John G, Douglas N, von Seidlein L, Nosten F, Baird J, White N . Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012; 11:280. PMC: 3489597. DOI: 10.1186/1475-2875-11-280. View

Peters A, van Noorden C . Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009; 57(11):1003-11. PMC: 2762880. DOI: 10.1369/jhc.2009.953828. View

Meister S, Plouffe D, Kuhen K, Bonamy G, Wu T, Barnes S . Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science. 2011; 334(6061):1372-7. PMC: 3473092. DOI: 10.1126/science.1211936. View

Lek-Uthai U, Suwanarusk R, Ruengweerayut R, Skinner-Adams T, Nosten F, Gardiner D . Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. Antimicrob Agents Chemother. 2008; 52(7):2435-41. PMC: 2443880. DOI: 10.1128/AAC.00169-08. View

10.

Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V . Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One. 2007; 2(10):e1089. PMC: 2034531. DOI: 10.1371/journal.pone.0001089. View

11.

Chotivanich K, Sattabongkot J, Choi Y, Park J, Sritabal J, Lim C . Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg. 2009; 80(6):902-4. PMC: 3444524. View

12.

Hopkins H, Gonzalez I, Polley S, Angutoko P, Ategeka J, Asiimwe C . Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013; 208(4):645-52. PMC: 3719898. DOI: 10.1093/infdis/jit184. View

13.

Modiano G, Battistuzzi G, Esan G, Testa U, Luzzatto L . Genetic heterogeneity of "normal" human erythrocyte glucose-6-phosphate dehydrogenase: an isoelectrophoretic polymorphism. Proc Natl Acad Sci U S A. 1979; 76(2):852-6. PMC: 383071. DOI: 10.1073/pnas.76.2.852. View

14.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera K . Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax. Antimicrob Agents Chemother. 2010; 55(3):961-6. PMC: 3067106. DOI: 10.1128/AAC.01220-10. View

15.

Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Phyo A, Valecha N . Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS One. 2011; 6(1):e14501. PMC: 3022577. DOI: 10.1371/journal.pone.0014501. View

16.

Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung R, Laihad F . Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007; 369(9563):757-765. PMC: 2532500. DOI: 10.1016/S0140-6736(07)60160-3. View

17.

Adak T, Valecha N, Sharma V . Plasmodium vivax polymorphism in a clinical drug trial. Clin Diagn Lab Immunol. 2001; 8(5):891-4. PMC: 96166. DOI: 10.1128/CDLI.8.5.891-894.2001. View

18.

Chen N, Auliff A, Rieckmann K, Gatton M, Cheng Q . Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis. 2007; 195(7):934-41. DOI: 10.1086/512242. View

19.

Sumawinata I, Bernadeta , Leksana B, Sutamihardja A, Purnomo , Subianto B . Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003; 68(4):416-20. View

20.

Price R, Marfurt J, Chalfein F, Kenangalem E, Piera K, Tjitra E . In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrob Agents Chemother. 2010; 54(12):5146-50. PMC: 2981240. DOI: 10.1128/AAC.00801-10. View